Letter to the editor: indacaterol/glycopyrronium/mometasone furoate compared with salmeterol/fluticasone propionate in patients with asthma: a randomized controlled cross-over study

Abstract Indacaterol (IND; 150 μg), glycopyrronium (GLY; 50 μg) and mometasone furoate (MF; 160 μg [high-dose ICS] and 80 μg [medium-dose ICS]) have been formulated as a once-daily (o.d.) fixed-dose combination treatment delivered via the Breezhaler® device for the treatment of patients with asthma....

Ful tanımlama

Detaylı Bibliyografya

Asıl Yazarlar:	Henrik Watz, Jens M. Hohlfeld, Dave Singh, Jutta Beier, Zuzana Diamant, Jinming Liu, Shucheng Hua, Khalid Abd-Elaziz, Pascale Pinot, Ieuan Jones, Hanns-Christian Tillmann
Materyal Türü:	Artigo
Dil:	Inglês
Baskı/Yayın Bilgisi:	BMC 2020-04-01
Seri Bilgileri:	Respiratory Research
Konular:	Indacaterol Glycopyrronium Mometasone Furoate Asthma
Online Erişim:	http://link.springer.com/article/10.1186/s12931-020-01349-5
Etiketler:	Etiketle Etiket eklenmemiş, İlk siz ekleyin!